The lumbar intervertebral body fusion device is indicated for use with autogenous bone graft in patients with degenerative disc disease at one or two contiguous levels from L2-S1. It can be implanted via posterior, transforaminal or lateral approach.
The device is a part of Interventional Spine’s family of Opticage Expandable Interbody Fusion Devices cleared for TLIF earlier this year.
More articles on devices:
Investor notes: 6 spine device company updates
Yale student scoliosis brace tracking device startup gets $100k
Vivex Biomedical acquires University of Miami Tissue Bank assets
